Literature DB >> 336194

Initiation and characterization of cultured tumor lines from spontaneous reticulum cell sarcoma of SJL/J mice.

M H Owens, B Bonavida.   

Abstract

Three reticulum cell sarcoma lines (LA1, LA6, and LA8) have been established from SJL/J spontaneous "Hodgkin's-like" reticulum cell sarcoma. All cultures are lymphoid with blast-like morphology by light and electron microscopy and produce the type B neoplasm (Dunn classification) when injected into young SJL/J mice. Identification of these tumors as lymphocytic and monocytic was investigated by surface markers, histochemical staining, and phagocytic function. LA6 and LA8 bear receptors for the Fc portion of immunoglobulin complement receptors; Thy 1.2 antigens and surface immunoglobulin were not detected on any of the three lines. No lines were able to synthesize immunoglobulin or phagocytose Degalon beads. Histochemical staining was presumptive of lymphocytes or lymphoblasts with slight differences between the lines. Although a T- or B-cell classification cannot definitively be made for these tumors lines because of their lack of specific markers, the results are consistent with an immature B-cell origin for the SJL/J reticulum cell sarcoma.

Entities:  

Mesh:

Year:  1977        PMID: 336194

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Intimate host-tumor interaction in the spontaneous reticulum cell sarcoma of SJL/J mice: is it an exceptional case?

Authors:  B Bonavida
Journal:  Surv Immunol Res       Date:  1985

2.  Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

Authors:  P K Pattengale; C R Taylor
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

3.  Hodgkin's disease. SJL/J murine lymphoma.

Authors:  R K Kumar
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

4.  Opsonization of tumor-reactive T cells in SJL/J mice bearing syngeneic tumors.

Authors:  I V Hutchinson; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.